October 13, 2014
BENGALURU, India—Olive Lifesciences published a review article on benefits and safety of coleus in the Journal of Oriental Pharmacy and Experimental Medicine.
The review describes well-established food and traditional use of coleus, its phytochemical information, biological effects and coleus safety assessment in both animals and humans. The published review covers up to date ethnopharmacological, phytochemical and pharmacological information of Coleus forskohlii, approaching toward its safety and therapeutic perspective.
Currently, Victoria University (Melbourne, Australia) is evaluating appetite suppressant properties associated with Olive’s Coleus forskohlii extract in overweight and obese individuals of Australian population. Victoria University is the primary sponsor of the study.
You May Also Like
The rise of ashwagandha: A case study in a growing and evolving category – articleNov 28, 2023
Ashwagandha: Roots for wellness, leaves for soil – articleNov 28, 2023
Creatine, whey protein, beta-alanine among picks in NFL-style draft at SupplySide WestDec 01, 2023
Unleash the power of ‘combos’ supplements to meet consumer demand – infographicNov 22, 2023